Starling Oncology Announces Third Quarter 2026 Earnings Release Date and Conference CallGlobeNewsWire · 2 days ago
Oncology Institute (NASDAQ:STLN) Shares Climb 6.1% – Should You Buy?Defense World · Oct 11, 2026
Cedar Grove Capital Q3 2026 Portfolio UpdateSeeking Alpha · Oct 7, 2026
Starling Oncology Leadership Highlights Recent and Upcoming Industry Conference ParticipationGlobeNewsWire · Oct 1, 2026
Starling Oncology: Improving Cash Flow And Gross Profit Fuel A Re-RatingSeeking Alpha · Sep 30, 2026
Starling Oncology to Participate in Wells Fargo Healthcare ConferenceGlobeNewsWire · Aug 24, 2026Starling Oncology, Inc., formerly The Oncology Institute, is a value-based oncology company advancing cancer care in the community setting. Founded in 2007, the company offers cutting-edge, evidence-based cancer treatments, including clinical trials and transfusions, to a large patient population. It operates as an integrated oncology platform serving patients, providers, and health plans across multiple markets with a focus on delivering high-quality, patient-centered care.
| Date | Est. | Actual | |
|---|---|---|---|
| Aug 6, 2026 | -$0.06 | -$0.08 | Miss |
| May 7, 2026 | -$0.09 | -$0.02 | Beat |
| Aug 13, 2025 | -$0.12 | -$0.15 | Miss |
| May 14, 2025 | – | -$0.21 | |
| Aug 13, 2024 | -$0.09 | -$0.17 | Miss |